EYEN - Eyenovia

-

$undefined

N/A

(N/A)

Eyenovia NASDAQ:EYEN Eyenovia, Inc. is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP) therapeutics. Eyenovia is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression and mydriasis.

Location: | Website: eyenoviabio.com | Industry: Medicinal and Botanical Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

12.21M

Cash

2.121M

Avg Qtr Burn

-7.53M

Short % of Float

2.95%

Insider Ownership

3.32%

Institutional Own.

2.46%

Qtr Updated

12/31/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.